Tag: Ndma contamination

In April 2020, the U.S. FDA requested that all ranitidine products, including Zantac, be removed from the market due to unacceptable levels of the probable carcinogen NDMA. This created a pressing question for millions: What replaced Zantac, and what are the safer alternatives for heartburn relief?

In 2020, the U.S. Food and Drug Administration (FDA) requested the immediate market withdrawal of all prescription and over-the-counter ranitidine products. This action effectively banned the popular acid reflux medicine, commonly known by the brand name Zantac, from the U.S. market due to potential contamination with a cancer-causing impurity.

In April 2020, the U.S. Food and Drug Administration (FDA) requested an immediate market withdrawal of all prescription and over-the-counter ranitidine drugs, including Rantac Syrup, due to potential contamination with a probable human carcinogen called N-nitrosodimethylamine (NDMA). Before this recall, ranitidine-based products like Rantac Syrup were widely used to treat and prevent conditions related to excess stomach acid.

The active ingredient in Zenremac 150 mg, ranitidine, was the subject of a global recall in 2020 by the FDA due to potential contamination with N-nitrosodimethylamine (NDMA), a probable human carcinogen. Before its withdrawal, Zenremac 150 mg was used to treat conditions caused by excess stomach acid, including heartburn, ulcers, and GERD.